StockDrifts LogoStockDrifts

General Atlantic L P 13F Portfolio

Portfolio Manager
General Atlantic L P
Performance
+8.39% (2026 Q2)
AUM (13F)
$2.91B
# of Holdings
12
Performance Rank
Allocation (Top 20)
73.08%
Latest filing
Q2 2026

General Atlantic L P Holdings Map

Top 9 General Atlantic L P Holdings

Top 10 holdings

StockCompany% Port.SharesValueActivityOwnershipAvg. CostDate
DLO
DLOCAL
20.86%46.66M$606.3M
+0.00%(+0)
2025-Q2: 63.91M shares2025-Q3: 46.66M shares2025-Q4: 46.66M shares2026-Q1: 46.66M shares2026-Q2: 46.66M shares
$48.69(-69.69%)
2026-06-30
CHYM
CHIME
14.98%21.26M$435.4M
+0.00%(+0)
2025-Q2: 19.21M shares2025-Q3: 19.21M shares2025-Q4: 21.26M shares2026-Q1: 21.26M shares2026-Q2: 21.26M shares
$33.37(-3.99%)
2026-06-30
ALKT
ALKAMI
12.08%19.38M$351.1M
+26.35%(+4.04M)
2025-Q2: 9.65M shares2025-Q3: 11.99M shares2025-Q4: 11.99M shares2026-Q1: 15.34M shares2026-Q2: 19.38M shares
$27.94(-25.63%)
2026-06-30
XP
XP, INC
11.5%20.57M$334.4M
+0.00%(+0)
2025-Q2: 25.52M shares2025-Q3: 25.52M shares2025-Q4: 22.70M shares2026-Q1: 20.57M shares2026-Q2: 20.57M shares
$31.76(-50.65%)
2026-06-30
PHVS
PHARVARIS
7.79%6.55M$226.5M
-18.43%(-1.48M)
2025-Q2: 7.53M shares2025-Q3: 8.03M shares2025-Q4: 8.03M shares2026-Q1: 8.03M shares2026-Q2: 6.55M shares
$22.24(+53.03%)
2026-06-30
NRIX
NURIX THERAPEUTICS
2.53%3.03M$73.6M
-26.08%(-1.07M)
2025-Q2: 0 shares2025-Q3: 0 shares2025-Q4: 4.90M shares2026-Q1: 4.10M shares2026-Q2: 3.03M shares
$14.10(+92.77%)
2026-06-30
RVMD
REVOLUTION MEDICINES
2.31%357.8K$67.0M
-49.45%(-350.00K)
2025-Q2: 0 shares2025-Q3: 2.47M shares2025-Q4: 2.81M shares2026-Q1: 707.8K shares2026-Q2: 357.8K shares
$44.32(+355.74%)
2026-06-30
RSKD
RISKIFIED
0.92%5.32M$26.8M
+0.00%(+0)
2025-Q2: 5.32M shares2025-Q3: 5.32M shares2025-Q4: 5.32M shares2026-Q1: 5.32M shares2026-Q2: 5.32M shares
$22.81(-71.72%)
2026-06-30
GROV
GROVE COLLABORATIVE
0.11%2.47M$3.1M
+0.00%(+0)
2025-Q2: 2.47M shares2025-Q3: 2.47M shares2025-Q4: 2.47M shares2026-Q1: 2.47M shares2026-Q2: 2.47M shares
$8.12(-87.30%)
2026-06-30

About General Atlantic L P’s portfolio

General Atlantic L P reports $2.91B in US-listed equity holdings across 12 positions in its most recent 13F filing. Its largest disclosed positions are DLO (20.9%), CHYM (15.0%) and ALKT (12.1%). The top 20 holdings account for 73.08% of reported assets. Its disclosed equity book has returned +30.55% on a three-year cumulative basis. Figures reflect the Q2 2026 filing.

Portfolio concentration

Portfolio concentration
DLO — 28.5% ($606.30M)CHYM — 20.5% ($435.40M)ALKT — 16.5% ($351.15M)XP — 15.7% ($334.41M)PHVS — 10.7% ($226.53M)NRIX — 3.5% ($73.56M)RVMD — 3.2% ($67.01M)RSKD — 1.3% ($26.84M)GROV — 0.1% ($3.09M)
100%in top 9
  • DLO28.5%
  • CHYM20.5%
  • ALKT16.5%
  • XP15.7%
  • PHVS10.7%
  • NRIX3.5%
  • RVMD3.2%
  • RSKD1.3%
  • GROV0.1%

Portfolio changes

What the fund actually did

Every reported change this quarter, grouped by direction. The signal is in the rotation, not any single trade.

Added to
1
ALKTALKAMI+26.4%
Trimmed
3
RVMDREVOLUTION MEDICINES-49.4%
PHVSPHARVARIS-18.4%
NRIXNURIX THERAPEUTICS-26.1%

Unlock alerts, watchlists & AI chat

Sign up free to track General Atlantic L P, compare funds side by side, and get alerts the moment positions change.

Source filings

Holdings on this page are parsed from General Atlantic L P’s Form 13F filings with the U.S. Securities and Exchange Commission (CIK 1017645). View General Atlantic L P’s 13F filings on SEC

More 13F analyses

View all